Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HYAL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REXO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB39A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPF40B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CELF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TULP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
STAT5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PDPN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCM3AP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP13A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on